These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18522547)

  • 1. Characterization of virus-specific T-cell immunity in liver allograft recipients with HCV-induced cirrhosis.
    Bharat A; Barros F; Narayanan K; Borg B; Lisker-Melman M; Shenoy S; Lowell J; Crippin J; Chapman W; Mohanakumar T
    Am J Transplant; 2008 Jun; 8(6):1214-20. PubMed ID: 18522547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis.
    Basha HI; Subramanian V; Seetharam A; Nath DS; Ramachandran S; Anderson CD; Shenoy S; Chapman WC; Crippin JS; Mohanakumar T
    Am J Transplant; 2011 Apr; 11(4):775-85. PubMed ID: 21446979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated soluble CD30 characterizes patients with hepatitis C virus-induced liver allograft cirrhosis.
    Bharat A; Narayanan K; Golocheikine A; Steward N; Crippin J; Lisker-Melman M; Shenoy S; Lowell J; Chapman WC; Mohanakumar T
    Transplantation; 2007 Dec; 84(12):1704-7. PubMed ID: 18165785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of optimal T-cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis.
    Sreenarasimhaiah J; Jaramillo A; Crippin J; Lisker-Melman M; Chapman WC; Mohanakumar T
    Hum Immunol; 2003 Feb; 64(2):224-30. PubMed ID: 12559624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma.
    Schirren CA; Jung MC; Gerlach JT; Worzfeld T; Baretton G; Mamin M; Hubert Gruener N; Houghton M; Pape GR
    Hepatology; 2000 Sep; 32(3):597-603. PubMed ID: 10960455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of peripheral blood CD4-positive T cells to carcinogenesis in patients with HCV-related chronic hepatitis and liver cirrhosis.
    Matsui T; Nagai H; Sumino Y; Miki K
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):401-6. PubMed ID: 17932673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ELISPOT analysis of hepatitis C virus protein-specific IFN-gamma-producing peripheral blood lymphocytes in infected humans with and without cirrhosis.
    Anthony DD; Post AB; Valdez H; Peterson DL; Murphy M; Heeger PS
    Clin Immunol; 2001 May; 99(2):232-40. PubMed ID: 11318595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon-alpha-treated patients with chronic hepatitis C.
    Hempel G; Galle PR; Löhr HF
    J Med Virol; 2001 Jul; 64(3):340-9. PubMed ID: 11424124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Th1/Th2 imbalance in HCV-related liver cirrhosis].
    Sakaguchi E; Kayano K; Segawa M; Aoyagi M; Sakaida I; Okita K
    Nihon Rinsho; 2001 Jul; 59(7):1259-63. PubMed ID: 11494534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus-specific T-cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesis.
    Li S; Vriend LE; Nasser IA; Popov Y; Afdhal NH; Koziel MJ; Schuppan D; Exley MA; Alatrakchi N
    Hepatology; 2012 Dec; 56(6):2094-105. PubMed ID: 22806830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication.
    Ciuffreda D; Comte D; Cavassini M; Giostra E; Bühler L; Perruchoud M; Heim MH; Battegay M; Genné D; Mulhaupt B; Malinverni R; Oneta C; Bernasconi E; Monnat M; Cerny A; Chuard C; Borovicka J; Mentha G; Pascual M; Gonvers JJ; Pantaleo G; Dutoit V
    Eur J Immunol; 2008 Oct; 38(10):2665-77. PubMed ID: 18958874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation.
    Subramanian V; Seetharam AB; Vachharajani N; Tiriveedhi V; Angaswamy N; Ramachandran S; Crippin JS; Shenoy S; Chapman WC; Mohanakumar T; Anderson CD
    Transplantation; 2011 Dec; 92(11):1259-68. PubMed ID: 22011763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.
    Gao Y; Ren H; Meng F; Li J; Cheung E; Li H; Zhao J; Liu H; Liu Z; Zhang M
    PLoS One; 2016; 11(4):e0154419. PubMed ID: 27123854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased frequency of interferon-gamma-producing peripheral blood CD4+ T cells in chronic hepatitis C virus infection.
    Kawakami Y; Nabeshima S; Furusyo N; Sawayama Y; Hayashi J; Kashiwagi S
    Am J Gastroenterol; 2000 Jan; 95(1):227-32. PubMed ID: 10638589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.
    Schirren CA; Jung M; Worzfeld T; Mamin M; Baretton GB; Gruener NH; Gerlach JT; Diepolder HM; Zachoval R; Pape GR
    Liver Transpl; 2000 Mar; 6(2):222-8. PubMed ID: 10719024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine profiles and hepatic injury in occult hepatitis C versus chronic hepatitis C virus infection.
    Mousa N; Eldars W; Eldegla H; Fouda O; Gad Y; Abousamra N; Elmasry E; Arafa M
    Int J Immunopathol Pharmacol; 2014; 27(1):87-96. PubMed ID: 24674682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.
    Glässner A; Eisenhardt M; Kokordelis P; Krämer B; Wolter F; Nischalke HD; Boesecke C; Sauerbruch T; Rockstroh JK; Spengler U; Nattermann J
    J Hepatol; 2013 Sep; 59(3):427-33. PubMed ID: 23665286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
    Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstitution of hepatitis C virus-specific T-cellmediated immunity after liver transplantation.
    Weston SJ; Leistikow RL; Reddy KR; Torres M; Wertheimer AM; Lewinsohn DM; Chou S; Davey MP; Corless C; O'Farrelly C; Nelson DR; Rosen HR
    Hepatology; 2005 Jan; 41(1):72-81. PubMed ID: 15619226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D3 modulates T lymphocyte responses in hepatitis C virus-infected liver transplant recipients.
    Almerighi C; Bergamini A; Lionetti R; Sinistro A; Lenci I; Tariciotti L; Tisone G; Angelico M
    Dig Liver Dis; 2012 Jan; 44(1):67-73. PubMed ID: 21930443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.